Table 1.
Analysis of clinic-pathological parameters and outcome in pure versus mixed SMCs, cross tabulation and t student test; NA: no data; DOD: died of disease; n: number of cases; LN: lymph node
| Pure SMC, n, % |
miSMC, n, % | p, OR, 95%CI | |
|---|---|---|---|
| Cases | 29 (55.76%) | 23 (44.23%) | |
| Age, median | 41.82 | 38.39 | p=0.316 (t-student test) |
| range | 22-78 | 26-60 | |
| Age <50 years | 22 | 21 | p=0.268; OR=3.341; (0.621-17.95) |
| >=50 years | 7 | 2 | |
| FIGO stage I | 20 | 16 | p=1; OR=1.042 (0.268-4.047) |
| II-IV | 6 | 5 | |
| Tumor size >=4cm | 5 | 3 | p=0.698; OR=1.765 (0.364-8.549) |
| <4cm | 17 | 18 | |
| NA | 7 | 2 | |
| FIGO histological grade G3 | 26 | 16 | p=0.08; OR=3.792; (0.855-16.813) |
| G1, G2 | 3 | 7 | |
| LVI Yes | 8 | 14 | p=0.08 OR=0.321; (0.09-1.059) |
| No | 16 | 9 | |
| NA | 5 | none | |
| Silva pattern C | 28 | 20 | p=0.310 OR=4.2; (0.406-43.399) |
| A, B | 1 | 3 | |
| LNM Yes | 5 | 7 | P=0.298 OR=0.298 (0.104-1.763) |
| No | 15 | 9 | |
| NA | 9 | 7 | |
| Local/pelvic recurrences Yes | 9 | 4 | p=0.324 OR=2.25 (0.566-8.93) |
| No | 15 | 15 | |
| NA | 5 | 4 | |
| Surgical treatment Radical with LN dissection | 17 | 9 | p=0.015 OR=5.289 (1.438-19.454) |
| Radical without LN | 5 | 14 | |
| NA | 7 | none | |
| Adjuvant treatment Yes | 11 | 7 | p=1 OR=0.982 (0.226-4.252) |
| No | 8 | 5 | |
| NA | 10 | 11 | |
| HPV status (HPV-testing) Positive | 15 | 7 | p=1 OR=0.41 (0.017-9.741) |
| Negative | 2 | 0 | |
| NA | 12 | 16 | |
| Outcome DOD | 5 | 2 | p=0.437 OR=2.237 (0.382-13.080) |
| Alive | 19 | 17 | |
| NA | 5 | 4 |